Thromboembolic Events in Severe COVID-19 Patients

  • STATUS
    Recruiting
  • participants needed
    300
  • sponsor
    University Hospital, Strasbourg, France
Send
Updated on 16 February 2024
See if I qualify
covid-19
thromboembolism
haemostasis
acute respiratory syndrome (sars)

Summary

The main objective of this study is to describe the incidence of thromboembolic events in a population of patients hospitalized in intensive care units in France for severe COVID-19. The secondary objective of this study is to describe the evolution of hemostasis parameters during the first two weeks of intensive care hospitalization and to evaluate the influence of different anticoagulation regimens on these parameters and on the incidence of thromboembolic events

Details
Condition Pulmonary Disease, Pulmonary Embolism, Pulmonary Embolism
Age 18years - 100years
Clinical Study IdentifierNCT04405869
SponsorUniversity Hospital, Strasbourg, France
Last Modified on16 February 2024

Eligibility

 Yes No Not Sure

Inclusion Criteria

Confirmed infection with the Sars-CoV-2 virus (RT-PCR)
Hospitalization in Intensive Care Unit
Age over 18 years Old

Exclusion Criteria

Refusal of the patient to participate in data collection
Clear my responses
Read more

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Browse trials for

covid-19
thromboembolism
haemostasis
acute respiratory syndrome (sars)

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.